Work

Blocking the action of NLRP3 inflammasome by inhaled ibuprofenate on pulmonary macrophages infected by SARS‐CoV‐2

Year: 2023

Type: article

Abstract: We present a Graphical Abstract that would represent the potential therapeutic effects of inhaled ibuprofenate on lung macrophages infected by SARS-CoV-2 and its link with the NLRP3 inflammasome. Furthermore, in the manuscript we will provide data on observational studies in pneumonias and Cards.

Source: Clinical and Translational Discovery

DOI: 10.1002/ctd2.169

Authors: Christian Carlos Zurita‐Lizza, Ignacio Rodriguez‐Sanchez, Pablo Alexis Doreski

Institutions: Argerich Hospital, Universidad de Buenos Aires

Language: English

Topic: Inflammasome and immune disorders

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $2,300